Press release
Irritable Bowel Syndrome Treatment Market is Growing at 8.7% CAGR to Surpass US$ 9,355.4 Million by 2034: Fact.MR Report
Irritable Bowel Syndrome Treatment Market
The market for treatments for irritable bowel syndrome is predicted to grow at a compound annual growth rate (CAGR) of 8.7% between 2024 and 2034, based on Fact.MR's study of market trends. By the end of 2034, the industry's net valuation is predicted to reach a whopping US$ 9,355.4 million if this profitable growth rate continues.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.factmr.com/connectus/sample?flag=S&rep_id=9520
The industry's present and upcoming technical and financial facts are accessible in the Irritable Bowel Syndrome Treatment Market 2024 Report. It is among the most extensive and significant additions to the library of market research studies from Prudent Markets. It provides thorough investigation and evaluation of the major facets of the worldwide market for treatments for irritable bowel syndrome. This study examines every significant aspect influencing the expansion of the worldwide market for treatments for irritable bowel syndrome, including the demand-supply situation, pricing strategies, profit margins, production, and value chain analysis.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐จ๐ซ ๐๐ซ๐ซ๐ข๐ญ๐๐๐ฅ๐ ๐๐จ๐ฐ๐๐ฅ ๐๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ:
North America (the USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America(Brazil, Mexico and Rest of Latin America)
Middle East & Africa(South Africa, GCC and Rest of the Middle East & Africa)
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
The emergence of players concentrating on other healthcare services earlier has made the global network of suppliers of irritable bowel syndrome treatment services more competitive. Due to the rising need for IBS patients' healthcare, small-scale market participants have gained prominence recently, especially in emerging economies.
Recent Developments by Irritable Bowel Syndrome Treatment Industry Participants
To raise awareness among patients with gastrointestinal diseases, Abbott Laboratories and the Nutrition Society of India collaborated to give clinical dietary recommendations specifically customized for the Indian market in March 2021. GI conditions such as functional constipation, peptic ulcers, chronic pancreatitis, and irritable bowel syndrome are anticipated to generate sufficient economic possibilities for Abbott in the nation.
Ferring B.V., a biopharmaceutical business, announced in June 2022 that it has teamed with I-MAB Biopharma Limited, a well-known biopharma company with an emphasis on innovation. Olamkicept is a selective interleukin-6 (IL-6) trans-signaling inhibitor that is being developed by the two businesses to treat inflammatory bowel disease (IBD) and related inflammatory diseases.
๐๐๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ซ ๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9520
๐๐๐ฒ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐ ๐๐ฒ ๐๐ซ๐ซ๐ข๐ญ๐๐๐ฅ๐ ๐๐จ๐ฐ๐๐ฅ ๐๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฎ๐ซ๐ฏ๐๐ฒ ๐๐๐ฉ๐จ๐ซ๐ญ
By Poduct Type:
Fiber Supplements
Anti-Diarrheal
Anticholinergic and Antispasmodic
Antidepressant
Antibiotics
Alosetron
Lubiprostone
Linaclotide
NHE3
By Indication:
Irritable Bowel Syndrome with Constipation
Irritable Bowel Syndrome with Diarrhea
Irritable Bowel Syndrome with Alternating Constipation and Diarrhea
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies and Stores
Hypermarkets and Supermarkets
Other Distribution Channels
By Region:
North America
Europe
Latin America
East Asia
South Asia & Oceania
The Middle East & Africa (MEA)
๐๐จ๐ง๐ญ๐๐๐ญ:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
๐๐๐จ๐ฎ๐ญ ๐ ๐๐๐ญ.๐๐
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irritable Bowel Syndrome Treatment Market is Growing at 8.7% CAGR to Surpass US$ 9,355.4 Million by 2034: Fact.MR Report here
News-ID: 3482218 • Views: โฆ
More Releases from Fact.MR
Zein Protein Market Expected to Grow to US$ 3.76 Billion by 2032
The global zein protein market (Margadh Prรณitรฉin Zein) is currently valued at $2.17 billion and is forecasted to grow to $3.76 billion by the end of 2032, with an expected compound annual growth rate (CAGR) of 5.3% over the next decade. This significant growth trajectory reflects the rising demand for sustainable protein sources and increased awareness of plant-based alternatives.
Zein, derived naturally from corn, has emerged as a versatile protein withโฆ
IT Infrastructure Monitoring Market to Grow at 17.3% CAGR, Reaching US$ 21.72 Bi โฆ
The global IT Infrastructure Monitoring Market (IT ์ธํ๋ผ ๋ชจ๋ํฐ๋ง ์์ฅ) is valued at US$ 4.4 billion in 2024 and is expected to grow to US$ 21.72 billion by the conclusion of 2034. IT infrastructure monitoring is evolving into a pivotal domain as organizations increasingly recognize the importance of maintaining the health, performance, and security of their IT ecosystems. IT infrastructure monitoring solutions and services are designed to monitor, analyze, andโฆ
Soy Sauce Powder Market Estimated to Reach US$ 602.8 Million by 2034
The global Soy Sauce Powder Market (Margadh Pรบdar Salann Soighe) is expected to reach a value of US$ 602.8 million by the end of 2034, with a projected growth rate of 5.5% over the coming decade. Driving this expansion is the shift in consumer tastes towards convenient and adaptable seasoning options. Research conducted by Fact.MR, a leading provider of market research and competitive intelligence, underscores the increasing popularity of soyโฆ
Reduced Fat Meat Market to Grow at 4.6% CAGR, Reaching US$ 15 Billion by 2033
The global reduced fat meat market (์ง๋ฐฉ์ด ์ ์ ๊ณ ๊ธฐ ์์ฅ) is projected to reach US$ 15 billion by the end of 2033, with demand expected to grow at a CAGR of 4.6% through 2033. Reducing the total fat content in processed meat is both desirable and feasible. Effective combinations of various fat substitutes can significantly lower levels of saturated fats and caloric content. These improvements lead to the development ofโฆ
More Releases for Irritable
Irritable Bowel Syndrome (IBS) Treatment Market: Increasing Prevalence of Irrita โฆ
The major factors such as the increasing prevalence of irritable bowel syndrome diseases and rising research & development activities drive the market growth. However, the limited number of product availability and treatment inefficiency restrain the market growth. IBS is a common chronic condition that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different thanโฆ
Ayurvedic Cure For Irritable Bowel Syndrome (IBS) Without Operation
The Grocare is a leading natural solution provider for chronic lifestyle diseases โ Irritable bowel syndrome (IBS), is a gift of enterprise, and commitment to quality and modern-day buyersโ changing needs. Grocare conforms to stringent quality-related compliances and cost-efficient processes in all aspects of formulation and production. At Grocare, we use natural ingredients developed over the years of research and development. It is FDA certified, safe to use, and affordableโฆ
Irritable Bowel Syndrome Treatment Market Value Projected to Expand by 2022
Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome affects the large intestine. Irritable bowel syndrome is associated with malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood test and endoscopy are normally performedโฆ
Irritable Bowel Syndrome Drugs and Companies Research
Summary
Irritable bowel syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. IBS is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least three months. IBS is classified into three main subtypes, according to the predominant bowel habit: constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), and mixed-presentation (IBS-M) IBS.
The IBS treatment landscape remains largely underserved, andโฆ
Irritable Bowel Syndrome Treatment Market Trends & Projection to 2022
Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome affects the large intestine. Irritable bowel syndrome is associated with malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood test and endoscopy are normally performedโฆ
Irritable Bowel Syndrome Treatment Market Forecasts, Trends and analysis 2023
A comprehensive analysis of the EMEA (Europe, Middle East and Africa) Irritable Bowel Syndrome Treatment Market is been done in this intelligence report. It includes the investigations done on the past progress, ongoing market scenarios, and future prospects. An accurate data of the products, strategies and market shares of leading companies in this particular market is mentioned. This report presents a 360-degree overview of the competitive scenario of the EMEAโฆ
